BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,641,902 | +17.2% | 43,505 | +41.5% | 0.01% | +20.0% |
Q2 2023 | $1,401,177 | +114844.8% | 30,754 | +2.3% | 0.01% | 0.0% |
Q1 2023 | $1,219 | -23.9% | 30,074 | -4.4% | 0.01% | -37.5% |
Q4 2022 | $1,602 | -99.9% | 31,446 | -0.9% | 0.01% | -11.1% |
Q3 2022 | $1,708,000 | -2.6% | 31,740 | +16.2% | 0.01% | 0.0% |
Q2 2022 | $1,754,000 | -28.9% | 27,315 | -14.2% | 0.01% | -25.0% |
Q1 2022 | $2,466,000 | -14.4% | 31,818 | -5.2% | 0.01% | -7.7% |
Q4 2021 | $2,881,000 | +3.3% | 33,572 | -3.2% | 0.01% | -13.3% |
Q3 2021 | $2,789,000 | -59.3% | 34,688 | -59.2% | 0.02% | -61.5% |
Q2 2021 | $6,848,000 | +31.1% | 85,075 | +37.3% | 0.04% | +11.4% |
Q1 2021 | $5,225,000 | -3.8% | 61,968 | -8.5% | 0.04% | -14.6% |
Q4 2020 | $5,433,000 | +11.2% | 67,721 | +11.4% | 0.04% | -10.9% |
Q3 2020 | $4,887,000 | -3.2% | 60,779 | +3.6% | 0.05% | -13.2% |
Q2 2020 | $5,050,000 | +29.9% | 58,647 | +22.4% | 0.05% | +3.9% |
Q1 2020 | $3,889,000 | +87.4% | 47,901 | +93.0% | 0.05% | +96.2% |
Q4 2019 | $2,075,000 | +9.4% | 24,817 | +14.5% | 0.03% | 0.0% |
Q3 2019 | $1,896,000 | +99.2% | 21,675 | +86.4% | 0.03% | +100.0% |
Q2 2019 | $952,000 | -3.5% | 11,628 | -4.2% | 0.01% | -7.1% |
Q1 2019 | $987,000 | +194.6% | 12,143 | +138.3% | 0.01% | +133.3% |
Q4 2018 | $335,000 | -14.8% | 5,095 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $393,000 | +4.5% | 5,095 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $376,000 | +15.3% | 5,095 | +1.7% | 0.01% | +20.0% |
Q1 2018 | $326,000 | – | 5,012 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |